Monjuvi (tafasitamab)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Monjuvi (tafasitamab), covering 2024-12-10 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders [Phase 2]